180 Life Sciences (ATNF) - 2024 Q4 - Annual Report
180 Life Sciences (ATNF)2025-03-31 20:15☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: __________ to __________ Commission File Number: 001-38105 180 LIFE SCIENCES CORP. (Exact name of registrant as specified in its charter) | Delaware | 90-1890354 ...